Fischer Medical Ventures has reported that its net profit in the September quarter was up over four times to ₹14 crore while income more than doubled to ₹89 crore. The company is engaged in the business of developing cost-effective medical imaging, advanced diagnostics and diagnostic solutions.

The company’s EBITDA grew multi-fold to ₹19 crore.

Ravindran Govindan, Chairman, Fischer Medical Ventures said the steep rise in profitability reflects the scalability of business, better product realisation and the growing acceptance of Fischer’s technology across India and overseas markets.

India’s MedTech and diagnostic industry is expanding rapidly, driven by government focus on indigenous manufacturing, preventive care and AI-led healthcare solutions, he said.

Fischer is well aligned with t

See Full Page